A prospective randomized clinical trial comparing two doses of AbobotulinumtoxinA for idiopathic overactive bladder.

Danielle de Sá Dantas BezerraLuis Gustavo Morato de ToledoSilvia da Silva CarramãoAntonio F Silva RodriguesCharles W ButrickAntonio P F Auge

Published in: Neurourology and urodynamics (2018)

Intravesical ABO injection at 500 U improves symptoms and quality of life for longer period of time than 300 U for idiopathic OAB.

Keyphrases